The Frankfurt Foundation Quality of Medicines presents Lifetime Achievement Award to Prof. Dr. A. Atilla Hincal
The Frankfurt Foundation Quality of Medicines presents the Lifetime Achievement Award to Prof. Dr. A. Atilla Hincal
The Frankfurt Foundation Quality of Medicines (FFQM) has honored Prof. Dr. Atilla Hincal, Pharmaceutical Technology at Hacettepe University Ankara/Turkey, with the Lifetime Achievement Award. Prof. Hincal was awarded for his extraordinary achievements in the field of pharmaceutical technology and outstanding contributions to improve the quality and effectiveness of medicines. We congratulate the award winner on this recognition of his life’s work.
The award ceremony took place on the occasion of the 21st International Pharmaceutical Technology Symposium (IPTS) in Ankara. Professor Hincal is the founding president of this event, which was the first international meeting for pharmaceutical science and technology in Turkey. It takes place every two years and has been accompanied by Prof. Hincal and his expertise for 40 years now.
The award winner was Dean of the Faculty of Pharmacy at Hacettepe University from 1981 to 1994 and then Dean of the Postgraduate Faculty of Health Sciences for a further three years. He was the founding director of the Turkish Doping Control Center (1988-94) and, in this capacity, Turkey’s representative on the European Anti-Doping Convention Council (1989-93). In addition, Prof. Hincal was the Director of the Revolving Fund of the Faculty of Pharmacy at Hacettepe University (1983-94) and the founder of the Hemodialysis Solutions Laboratory and Production Facility at Hacettepe University (1984-94). He also established the first Drug and Poison Information Center at a university in Turkey and directed it as well as the Interdisciplinary Instrumental Research Laboratory at Hacettepe University for many years. Finally, he was the founder and first president of the Turkish Pharmaceutical Technology Scientists‘ Association (Tüftad), which became a member of the European Federation for Pharmaceutical Societies (EUFEPS) as a Turkish pharmaceutical scientific society.
Prof. Hincal’s research focuses on the development of dosage forms for cancer drugs based on nanosystems (liposomes, microspheres, nanoparticles), as well as biotechnological drugs, orphan drugs and bioavailability/bioequivalence.
Prof. Dr. Gerrit Borchardt from the University of Geneva (Switzerland) gave the laudatory speech for the award-winner, who outlined some of the highlights of Prof. Hincal’s scientific career.
The Awardee published more than 250 scientific papers, given more than 300 scientific presentations, is author of 20 books with his team members.
In recognition of his scientific work, he has received numerous awards including from the Czechoslovak Academy of Medical and Pharmaceutical Sciences, the American Association for Pharmaceutical Scientists (AAPS) and the French National Academy of Pharmacy. He has also received the Scientific Achievement Award from the Turkish Academy of Pharmaceutical Sciences, the Lifetime Achievement in Pharmaceutical Sciences Award from the Federation International Pharmaceutique (FIP), the Education and Research Award from the Indian Society of Pharmaceutical Dissolution Sciences and the Renault Award for Scientific Achievement in Sports from the Turkish National Olympic Committee.
As a result of his scientific work, Professor Hincal has received honorary doctorates from two universities.
The Chairman of the Board of the Frankfurt Foundation Quality of Medicines, Prof. Dr. Dr. h.c. Henning Blume, presented the prizewinner with the award certificate and the Gömböc, the traditional sculpture for the FFQM Lifetime Achievement Award.
In his words of thanks, Professor Hincal expressed his delight at receiving the award for his life’s work and thanked the founders Dagmar and Henning Blume for this special honor.
Professor Hincal is the fourth pharmaceutical scientist to be awarded a Gömböc by the FFQM for his life’s work. The previous winners of the Lifetime Achievement Award are
– Professor emeritus Dr. José Augusto Guimarães Morais from the Department of Pharmacological Sciences of the Faculty of Pharmacy of the University of Lisbon/Portugal (2021).
– Professor Dr. Laszlo Endrenyi from the Department of Pharmacology & Toxicology at the University of Toronto/Canada (2021 posthumously)
– Professor Dr. Leslie Z. Benet from the University of California San Francisco (UCSF) (2023).
